FRANKFURT, June 4 Wed Jun 4, 2014 5:34am EDT
FRANKFURT, June 4 (Reuters) - Stada is in negotiations over several potential takeover targets as it pursues its expansion strategy, the chief executive of the German maker of generic and non-prescription drugs said on Wednesday.
"We are currently in talks over a number of very promising transactions," CEO Hartmut Retzlaff said in the text of a speech to shareholders, without giving details of the targets.
Retzlaff also affirmed Stada's guidance for a slight rise in sales, adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) and adjusted net profit in 2014.
The company has no plans for a cost cutting programme at the moment, he added. (Reporting by Frank Siebelt, writing by Jonathan Gould)
FRANKFURT, June 4 (Reuters) - Stada is in negotiations over several potential takeover targets as it pursues its expansion strategy, the chief executive of the German maker of generic and non-prescription drugs said on Wednesday.
"We are currently in talks over a number of very promising transactions," CEO Hartmut Retzlaff said in the text of a speech to shareholders, without giving details of the targets.
Retzlaff also affirmed Stada's guidance for a slight rise in sales, adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) and adjusted net profit in 2014.
The company has no plans for a cost cutting programme at the moment, he added. (Reporting by Frank Siebelt, writing by Jonathan Gould)
via Smart Health Shop Forum http://ift.tt/1iU3F9F
No comments:
Post a Comment